Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS
Point72 Asset Management, L.P.'s stake in Corvus Pharmaceuticals, Inc. fell below 5% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Point72 Asset Management, L.P.'s stake in Corvus Pharmaceuticals, Inc. fell below 5%, 0 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 0% | 0 |
| Point72 Capital Advisors, Inc. | 0% | 0 |
| Steven A. Cohen | 0% | 0 |
Source
Related
- Corvus Pharmaceuticals, Inc.
- Point72 Asset Management, L.P.
- Corvus Pharmaceuticals, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Moore David Scott · Jun 15, 2026
- Form 4 · Miller Richard A Md · May 20, 2026
- Schedule 13G · Sirenia Capital Management LP · May 15, 2026